Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€208.80
07.09.22
€300.00
31.12.24
13.84%
30.08.24

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
15.44%
19.08.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€50.50
07.09.22
€80.00
31.12.24
-29.90%
05.05.23

Could be very worthwhile Investment >20% year
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.22
07.09.22
€100.00
31.12.25
73.41%
14.12.22

Could be very worthwhile Investment >20% year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
-3.72%
28.08.24

Could be very worthwhile Investment >20% year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€0.81
07.09.22
€2.00
31.12.24
72.58%
09.12.22

Could be very worthwhile Investment >20% year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€9.70
07.09.22
€20.00
31.12.24
-76.29%
05.05.23

Could be very worthwhile Investment >20% year
buy
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€4.55
06.09.22
-
06.09.23
-53.45%
06.09.23

Valneva SE

Start price
Target price
Perf. (%)
€8.01
05.09.22
-
05.10.26
-57.57%
11.03.24

Probably not worthwhile Investment
MorphoSys AG

Start price
Target price
Perf. (%)
€16.57
05.09.22
-
05.10.26
293.97%
11.03.24

Probably not worthwhile Investment
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.06
05.09.22
-
05.09.23
-46.97%
24.04.23

Probably not worthwhile Investment
buy
China SXT Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.19
05.09.22
-
05.09.23
-90.57%
06.09.23

Revenue growth >5% per year expected
Probably not worthwhile Investment
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.12
04.09.22
-
04.09.23
-11.64%
15.10.22

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.63
04.09.22
-
04.09.23
-6.99%
18.09.22

Could be worthwhile Investment >10% per year
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€3.06
03.09.22
-
03.09.23
-86.05%
24.04.23

Risky Investment
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.76
02.09.22
-
02.09.23
-10.51%
27.09.22

Could be very worthwhile Investment >20% year
Abivax S.A.

Start price
Target price
Perf. (%)
€8.30
02.09.22
€5.00
31.12.24
85.30%
08.05.23

Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€14.42
29.08.22
-
29.08.23
-59.22%
19.05.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€7.13
26.08.22
-
26.08.23
-14.99%
03.09.22

Probably not worthwhile Investment
buy
Invitae Corp

Start price
Target price
Perf. (%)
€3.32
26.08.22
-
26.08.23
-17.03%
03.09.22

Could be very worthwhile Investment >20% year
buy
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€31.05
25.08.22
-
25.08.23
-14.11%
26.08.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€90.50
24.08.22
€120.00
24.08.23
17.79%
08.05.23

Could be worthwhile Investment >10% per year